Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Whoon Jong KilDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Romaine C. Nichols JrDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USACorrespondence[email protected]

Bradford S. HoppeDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Christopher G. MorrisDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Robert B. Marcus JrDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

William MendenhallDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Nancy P. MendenhallDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Zuofeng LiDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

Joseph A. CostaDivision of Urology, University of Florida Shands Hospital, Jacksonville, Florida, USA

Christopher R. WilliamsDivision of Urology, University of Florida Shands Hospital, Jacksonville, Florida, USA

Randal H. HendersonDepartment of Radiation Oncology, University of Florida, Gainesville, Florida, USA;University of Florida Proton Therapy Institute, Jacksonville, Florida, USA

show all

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Table I. Pretreatment patient characteristics.

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression

Figures & data

Table I. Pretreatment patient characteristics.

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date